OPTIMIZATION OF ANTIBACTERIAL THERAPY FOR RESPIRATORY DISEASES IN CHILDREN UNDER 5 YEARS: A COMPREHENSIVE PHARMACOECONOMIC ABC ANALYSIS
Keywords:
ABC analysis, antibacterial drugs, bronchopulmonary diseases, pediatrics, children under 5, pharmacoeconomics, antibiotic stewardship, respiratory infections, cost optimization.Abstract
This article presents a comprehensive ABC analysis of the utilization patterns of antibacterial drugs (ABDs) in the treatment of bronchopulmonary diseases among children under 5 years of age. Conducted across two distinct clinical departments of the Tashkent Pediatric Medical Institute, this study employed a retrospective pharmacoeconomic methodology, analyzing medical records of pediatric patients hospitalized between January and March 2024. The primary objective was to categorize ABDs based on their frequency of prescription and associated financial burden, thereby identifying key drivers of clinical expenditure and prescribing habits. The ABC analysis successfully delineated high-priority medications, contributing valuable insights for optimizing pharmacotherapy and promoting the rational allocation of clinical resources. The findings revealed notable disparities in the prescription structures between the observed departments, underscoring the absence of a unified therapeutic protocol. These variations highlight an urgent need for the revision and standardization of treatment guidelines to ensure both clinical efficacy and economic sustainability. Furthermore, this research underscores the critical role of continuous antimicrobial stewardship in pediatric settings to mitigate the escalating threat of antibiotic resistance, improve patient outcomes, and reduce unnecessary healthcare costs.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
